TipRanks
Atrys Health SA (DE:A2T)
FRANKFURT:A2T

Compare Atrys Health SA (A2T) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Atrys Health SA
€2.85
€192.23M
-1.99
-8.40%
―
Oryzon Genomics SA
€2.86
€221.29M
-87.12
-18.74%
2 Buy
0 Hold
0 Sell
Moderate Buy
Pharma Mar SA
€82.80
€1.24B
21.54
-22.28%
1 Buy
0 Hold
0 Sell
Moderate Buy
1nKemia IUCT Group SA
€0.31
€8.21M
―
0.00%
―
PRIM, S.A.
€13.20
€211.01M
16.64
-7.33%
―
Labiana Health SA
€6.20
€48.81M
16.21
35.14%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:A2T
Atrys Health SA
2.40
-0.83
-25.70%
ES:ORY
Oryzon Genomics SA
2.72
-0.79
-22.45%
ES:PHM
Pharma Mar SA
70.30
-16.59
-19.09%
ES:IKM
1nKemia IUCT Group SA
0.31
0.00
0.00%
ES:PRM
PRIM, S.A.
12.65
-0.42
-3.21%
ES:LAB
Labiana Health SA
5.70
1.48
35.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts